熱門資訊> 正文
Atara Biotherapeutics将裁员30%
2025-05-13 04:22
- Atara Biotherapeutics (NASDAQ:ATRA) announced on Monday a reduction in its workforce that will impact approximately 30% of its current employees, retaining approximately 23 employees essential to executing on the company’s strategic priorities.
- The company expects to complete the workforce reduction by August 2025. The company expects to recognize approximately $1.4M for severance and related benefits for employees laid off under the reduction in force.
- These charges are primarily one-time termination benefits and are primarily cash charges. The company may also incur other charges or cash expenditures not currently contemplated.
- Atara Biotherapeutics (NASDAQ:ATRA) shares were up more than 8% in extended trading.
More on Atara Biotherapeutics
- Seeking Alpha’s Quant Rating on Atara Biotherapeutics
- Historical earnings data for Atara Biotherapeutics
- Financial information for Atara Biotherapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
